CD137 (4-1BB)
Showing 1 - 25 of >10,000
Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)
Recruiting
- Metastatic Colorectal Cancer
- RO7122290
- +2 more
-
Toronto, Ontario, Canada
- +15 more
Jan 13, 2023
Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)
Not yet recruiting
- Advanced/Metastatic Solid Tumors
-
Kurralta Park, South Australia, Australia
- +1 more
Nov 9, 2022
Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)
Not yet recruiting
- Leukemia, Myeloid, Acute
- CD33KO-HSPC; CART33
- (no location specified)
Jul 13, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia, Refractory Trial in Philadelphia
Recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CART123 cells; cyclophosphamide; fludarabine
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Feb 28, 2022
Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Multiple Myeloma (MM)
- 3x10(6) CART-38 cellls
- +5 more
- (no location specified)
Jul 15, 2022
Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in Milwaukee (CAR-20/19-T cells (1.0 x10^5
Completed
- Lymphoma, Non-Hodgkin
- +3 more
- CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg)
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & Medical College of Wisconsin
Jun 26, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed
Recruiting
- Relapsed Non Hodgkin Lymphoma
- +2 more
- autologous CD19-directed chimeric antigen receptor (CAR) T-cells
-
Calgary, Alberta, Canada
- +5 more
Jul 18, 2022
Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)
Not yet recruiting
- Malignant Solid Tumor
- GEN1042
- +4 more
- (no location specified)
Sep 21, 2023
HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,
Completed
- HER2 Positive Breast Carcinoma
- +6 more
- Utomilumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 22, 2022
DLBCL, Not Otherwise Specified, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Seattle
Terminated
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- +5 more
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
Large B-cell Lymphoma Trial in Philadelphia (mosunetuzumab, glofitamab, obinutuzumab)
Recruiting
- Large B-cell Lymphoma
- mosunetuzumab
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jul 21, 2022
Cancer Trial in Houston (LVGN7409)
Recruiting
- Cancer
- LVGN7409
-
Houston, TexasMD Anderson Cancer Center
Apr 4, 2022
B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- B-cell Non Hodgkin Lymphoma
- CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
-
Aurora, ColoradoChildren's Hospital Colorado
Nov 9, 2022
Locally Advanced or Metastatic Solid Tumors, Squamous-cell NSCLC Trial in Shanghai, Xuzhou (HLX35)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- Squamous-cell Non-small Cell Lung Cancer
-
Shanghai, China
- +1 more
Jun 28, 2022
Non-CNS Tumor Trial (biological, drug, radiation)
Not yet recruiting
- Non-CNS Tumor
- GEN1042
- +2 more
- (no location specified)
Aug 4, 2022
Advanced Solid Tumor Trial in Amsterdam, Groningen (89Zr-S095012 tracer and S095012 will be administered via an IV infusion)
Recruiting
- Advanced Solid Tumor
- 89Zr-S095012 tracer and S095012 will be administered via an IV infusion
-
Amsterdam, Netherlands
- +1 more
Dec 9, 2022
![](/image/sponsor/kazakhstan's_medical_university_"ksph")
Health Status of Children Born After Assisted Reproductive
Recruiting
- Children Born After Assisted Reproductive Technologies
- +2 more
- hemogram examination
-
Almaty, KazakhstanSevara ilmuratova
Oct 17, 2023
Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction
Not yet recruiting
- Hiv
- +5 more
- differences in CD4 reconstruction
- (no location specified)
Sep 17, 2023
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia
Recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +5 more
- CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
- +4 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Sep 22, 2022